Read + Share
Amedeo Smart
Independent Medical Education
Murciano-Goroff YR, Lin ST, Wilhelm C, Iasonos A, et al. In Reply to "Selpercatinib Controls Central Nervous System Disease in Patients With RET Fusion-Positive NSCLC". J Thorac Oncol 2023;18:e52-e53.PMID: 37087124
Email
LinkedIn
Facebook
Twitter
Privacy Policy